Free radicals and antioxidants status in neonates with congenital malformation

Bedabrata Mukhopadhyay1, Ajay Narayan Gongopadhyay2, Anjali Rani3

  • 1Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Insights

Oxidative stress markers are elevated in newborns with congenital anomalies, indicating a potential role in birth defect development. This imbalance between oxidants and antioxidants may contribute to infant mortality from congenital malformations.

Area of Science:

  • Biochemistry
  • Neonatology
  • Pediatric Research

Background:

  • Oxidative stress during pregnancy is implicated in birth defects via animal models.
  • Congenital anomalies cause significant infant mortality globally.
  • Research is ongoing to reduce congenital anomaly-related infant deaths.

Purpose of the Study:

  • To quantify oxidant and antioxidant levels in newborns with congenital anomalies.
  • To compare these levels against age- and sex-matched healthy neonates.
  • To investigate the potential role of oxidative stress in congenital anomaly causation.

Main Methods:

  • A case-control study involving 159 neonates (106 with congenital anomalies, 53 healthy controls).
  • Measurement of serum malondialdehyde (MDA) and protein carbonyl (PC) as oxidative stress markers.
  • Assay of antioxidant levels, including Vitamin C and glutathione.

Main Results:

  • Newborns with congenital malformations exhibited significantly higher MDA and PC levels (P < 0.0001).
  • Significantly lower Vitamin C and reduced glutathione levels were observed in neonates with congenital anomalies (P < 0.0001).

Conclusions:

  • Elevated lipid peroxidation and protein carbonylation may contribute to congenital anomaly pathogenesis.
  • An impaired free radical/antioxidant balance leads to increased free radical damage in affected neonates.
  • Findings highlight oxidative stress as a key factor in congenital malformations.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
3.4K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
109